THE SMOKING GUN: DIAGNOSIS VS. TREATMENT
THEY SAID
SCHIZOPHRENIA/PSYCHOSIS DIAGNOSIS
"Patient meets criteria for schizophrenia" - Formal diagnosis, 2020
Professor Dennerstein's 2020 report explicitly diagnosed schizophrenia and recommended urgent antipsychotic intervention, creating a permanent medical record that followed for years.
PERPETUATED DIAGNOSIS: "PER DENNERSTEIN"
2020-2024: Diagnosis recycled through multiple assessments without verification
Multiple practitioners and agencies referenced "per Dennerstein" as the diagnostic authority without conducting independent evaluations, creating a self-reinforcing cycle of an unverified diagnosis.
ESA 2023: SCHIZOPHRENIA LISTED AS BARRIER
Employment Services Assessment formally cited schizophrenia as employment barrier
The 2023 ESA (JSKID - 3420718409) explicitly referenced the schizophrenia diagnosis as a primary barrier to employment, limiting work capacity assessment to 8-14 hours/week and labeling as "Moderate non-compliance."
ATTEMPTED INVOLUNTARY SECTIONING
Labeled "suicidal" and "danger to myself but to society"
Dr. Scott Wilsmore attempted involuntary sectioning under the Mental Health Act 2007 based on disputed diagnosis, demonstrating the real-world consequences of the diagnostic record.
WHAT HAPPENED
STIMULANTS PRESCRIBED, NOT ANTIPSYCHOTICS
Duromine/Metermine (phentermine) - stimulants known to worsen psychosis
Pharmacy records confirm only stimulant medications were prescribed and dispensed during the same period as the schizophrenia diagnosis - a fundamental medical contradiction as stimulants are contraindicated for psychosis.
NO ANTIPSYCHOTICS EVER PRESCRIBED
Complete absence of standard-of-care treatment for diagnosed condition
Despite a diagnosis that would require urgent antipsychotic intervention, pharmacy records confirm no antipsychotic medications were ever prescribed or dispensed - a glaring clinical contradiction.
CONTRADICTORY MEDICAL ASSESSMENTS
Dr. Chauhan (2025): ADHD, ASD Level 2, PTSD, Schizotypal Disorder
Dr. Manish Chauhan's 2025 comprehensive assessment provided a fundamentally different diagnostic picture, recommending Clonidine and Lisdexamfetamine (stimulants) - treatment that would be inappropriate and dangerous for schizophrenia.
SUDDEN ADMINISTRATIVE REVERSAL
2019 "temporary" → 2024 "permanent," no clinical change
After 5 years of classifying the condition as "temporary" and denying appropriate support, Services Australia suddenly reclassified the same condition as "permanent" in 2024 with no new medical evidence, demonstrating administrative inconsistency rather than clinical reality.
